Andel

Venture-backed company · Stage unknownandel.org

Andel is a revolution in drug affordability — a cooperative technology platform that unlocks access to GLP-1s and other high-spend medications.

Rounds on record
1
Latest round
Oct 20, 2025
Funding round
Latest round size
$4.5M
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

2 additional investors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. $4.5M
    announced

    Announced a $4.5M round on 20 Oct 2025.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactPress release wires (PR Newswire, GlobeNewswire)For Investors, lenders, service providersFinancing history →
  2. 4 investors
    named

    4 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$4.5Msum of rounds with a disclosed amount only
Named investors
4

Financing history

1 round
  1. Oct 20, 2025
    Funding round · $4.5M (disclosed)
    Lightbank (participant)Bertelsmann Healthcare Investments (participant) via Thorsten WirkesHoughton Street Ventures (participant)Seedcamp Investment Management LLP (participant) via Reshma Sohoni
    Fact Press release · “Andel Raises $4.5M for Its Employer-Supported Medication Marketplace”

Investors on record

5 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

0 officers, 0 directors
No officer or director on record.

Timeline

1 event
  1. Oct 20, 2025
    Andel announced Funding round of $4,500,000
    Round announced Fact Press release

Evidence

7 observations
Every observation on this company
  • Description: Sep 16, 2026 Fact
  • Listed on portfolio page: Sep 30, 2026 Fact
  • Listed on portfolio page: Sep 16, 2026 Fact
  • Listed on portfolio page: Sep 13, 2026 Fact
  • Round announced: Funding round $4,500,000 Oct 20, 2025 Fact Press release
  • Website status: ok Sep 16, 2026 Fact
  • Site title: Sep 16, 2026 Fact

Record history

1 identity change, 1 dated event on the change ledger, latest event first
  • Renamed
    2026-09-13
  • Round announced
    2025-10-20source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.